Free Trial

M&T Bank Corp Grows Holdings in Ventas, Inc. $VTR

Ventas logo with Finance background
Image from MarketBeat Media, LLC.

Key Points

  • M&T Bank increased its stake in Ventas by 111% in Q4, now owning 79,887 shares valued at about $6.18 million.
  • Ventas reported Q1 EPS of $0.11 (missed by $0.01) while revenue beat at $1.65 billion, and management set FY2026 guidance of $3.820–$3.890 EPS with analysts' consensus EPS ~3.85 and a consensus target price of $93.19.
  • Ventas raised its quarterly dividend to $0.52 ($2.08 annualized, ~2.4% yield), but the company shows a very high reported payout ratio of 378.18%.
  • Five stocks to consider instead of Ventas.

M&T Bank Corp increased its position in Ventas, Inc. (NYSE:VTR - Free Report) by 111.0% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 79,887 shares of the real estate investment trust's stock after acquiring an additional 42,020 shares during the quarter. M&T Bank Corp's holdings in Ventas were worth $6,181,000 at the end of the most recent quarter.

Other institutional investors have also added to or reduced their stakes in the company. Cloud Capital Management LLC purchased a new stake in Ventas during the 3rd quarter valued at approximately $25,000. GoalVest Advisory LLC purchased a new stake in Ventas during the 4th quarter valued at approximately $26,000. Wiser Advisor Group LLC purchased a new stake in Ventas during the 3rd quarter valued at approximately $27,000. ORG Partners LLC grew its holdings in Ventas by 76.1% during the 3rd quarter. ORG Partners LLC now owns 456 shares of the real estate investment trust's stock valued at $32,000 after buying an additional 197 shares in the last quarter. Finally, Wilmington Savings Fund Society FSB grew its holdings in Ventas by 65.5% during the 3rd quarter. Wilmington Savings Fund Society FSB now owns 455 shares of the real estate investment trust's stock valued at $32,000 after buying an additional 180 shares in the last quarter. 94.18% of the stock is owned by hedge funds and other institutional investors.

Ventas Price Performance

Ventas stock opened at $86.74 on Wednesday. The company has a market cap of $42.17 billion, a price-to-earnings ratio of 157.71, a PEG ratio of 2.16 and a beta of 0.74. The firm's fifty day moving average is $84.81 and its 200 day moving average is $80.33. The company has a quick ratio of 0.25, a current ratio of 0.25 and a debt-to-equity ratio of 0.95. Ventas, Inc. has a 52-week low of $61.76 and a 52-week high of $88.50.

Ventas (NYSE:VTR - Get Free Report) last released its quarterly earnings results on Monday, April 27th. The real estate investment trust reported $0.11 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.12 by ($0.01). The business had revenue of $1.65 billion for the quarter, compared to analysts' expectations of $1.59 billion. Ventas had a net margin of 4.25% and a return on equity of 2.09%. Ventas's revenue for the quarter was up 22.0% compared to the same quarter last year. During the same period in the previous year, the company earned $0.84 EPS. Ventas has set its FY 2026 guidance at 3.820-3.890 EPS. Sell-side analysts forecast that Ventas, Inc. will post 3.85 EPS for the current fiscal year.

Ventas Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Thursday, April 16th. Investors of record on Tuesday, March 31st were paid a dividend of $0.52 per share. The ex-dividend date of this dividend was Tuesday, March 31st. This is a positive change from Ventas's previous quarterly dividend of $0.48. This represents a $2.08 dividend on an annualized basis and a yield of 2.4%. Ventas's payout ratio is currently 378.18%.

Analyst Upgrades and Downgrades

Several research analysts have commented on VTR shares. KeyCorp increased their price objective on shares of Ventas from $85.00 to $90.00 and gave the company an "overweight" rating in a report on Tuesday, February 10th. JPMorgan Chase & Co. increased their price objective on shares of Ventas from $88.00 to $93.00 and gave the company an "overweight" rating in a report on Friday, March 20th. UBS Group increased their price objective on shares of Ventas from $85.00 to $93.00 and gave the company a "neutral" rating in a report on Monday. Scotiabank increased their price objective on shares of Ventas from $80.00 to $93.00 and gave the company a "sector perform" rating in a report on Monday, March 2nd. Finally, The Goldman Sachs Group reissued a "buy" rating and set a $100.00 price objective on shares of Ventas in a report on Monday, February 9th. Fourteen investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $93.19.

View Our Latest Stock Analysis on Ventas

Insider Transactions at Ventas

In related news, EVP Carey S. Roberts sold 35,532 shares of the company's stock in a transaction on Wednesday, February 11th. The shares were sold at an average price of $85.00, for a total transaction of $3,020,220.00. Following the sale, the executive vice president owned 72,755 shares of the company's stock, valued at $6,184,175. This represents a 32.81% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 0.53% of the stock is currently owned by insiders.

Ventas Company Profile

(Free Report)

Ventas, Inc NYSE: VTR is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas' business model combines property ownership with active asset management and capital markets activity.

Featured Articles

Want to see what other hedge funds are holding VTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ventas, Inc. (NYSE:VTR - Free Report).

Institutional Ownership by Quarter for Ventas (NYSE:VTR)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Ventas Right Now?

Before you consider Ventas, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ventas wasn't on the list.

While Ventas currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 7 Hottest IPOs On Wall Street’s 2026 Watchlist Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines